APA (7th ed.) Citation

Radujković, A., Fruehauf, S., Zeller, W. J., Ho, A. D., & Topaly, J. (2010). Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells. Cancer chemotherapy and pharmacology, 66(2), . https://doi.org/10.1007/s00280-009-1158-7

Chicago Style (17th ed.) Citation

Radujković, Aleksandar, Stefan Fruehauf, W. Jens Zeller, Anthony Dick Ho, and Julian Topaly. "Synergistic Activity of Nilotinib and Established Chemotherapeutic Drugs in Imatinib-sensitive and -resistant BCR-ABL-positive Cells." Cancer Chemotherapy and Pharmacology 66, no. 2 (2010). https://doi.org/10.1007/s00280-009-1158-7.

MLA (9th ed.) Citation

Radujković, Aleksandar, et al. "Synergistic Activity of Nilotinib and Established Chemotherapeutic Drugs in Imatinib-sensitive and -resistant BCR-ABL-positive Cells." Cancer Chemotherapy and Pharmacology, vol. 66, no. 2, 2010, https://doi.org/10.1007/s00280-009-1158-7.